The New Scientist examines the recent claims of advances in stem cell research by a UK company called TriStem. The research has not yet been widely confirmed by independent scientific review (and is thus suspect), but if true it is very promising indeed. In short, TriStem claim to be able to get adult stem cells to behave like embryonic stem cells. This would speed development of regenerative medicine, sidestep ethical and legislative concerns and lower costs all round. The article notes that the first peer-reviewed confirmation has just appeared, but scientists are still justifiably skeptical.